Pernod Ricard SA (XSWX:RI)
CHF 188 0 (0%) Market Cap: 51.46 Bil Enterprise Value: 61.21 Bil PE Ratio: 15.64 PB Ratio: 1.96 GF Score: 75/100

Full Year 2024 Pernod Ricard SA Earnings Call Transcript

Aug 29, 2024 / 07:00AM GMT

Key Points

Positve
  • Pernod Ricard SA (PDRDF) achieved organic gross margin expansion of 108 basis points and organic operating margin expansion of 80 basis points.
  • The company experienced sequential volume recovery in most markets during the second half of the fiscal year.
  • Strong performance in mature and emerging markets, excluding the impact of exiting Russia.
  • Continued investment in brand desirability and sustainability for long-term growth.
  • Positive price mix across the board, benefiting from previous year's price increases.
Negative
  • Organic net sales were broadly stable at minus 1%, impacted by the exit from Russia.
  • Weak performance in the United States and China, with the US market down 9% and China down 10%.
  • Reported profit from recurring operations declined by 7% due to negative foreign currency impacts.
  • EPS decreased by 13% due to higher financial expenses from recent refinancing at higher rates.
  • The company faced a challenging macroeconomic environment in China, impacting consumer demand and sales.
Operator

Good morning, everyone. We're very pleased to welcome you at our fiscal year 2024 full-year sales and results presentation. Alexandre and Hélène will take you through the slides, and then we will follow up with a Q&A session. Alexandre, it's to you.

Alexandre Ricard
Pernod Ricard SA - Chairman of the Board, CEO, Member of the Executive Board, & Member of the Executive Committee

Great. Well, thank you, and good morning to all. I really hope you had a great sportive summer. So let's directly dive into our fiscal year '24 sales and results. So we've had a robust performance in what we can qualify a normalizing spirits market with organic net sales broadly stable at minus 1%, which would have been plus 1% excluding the exit from Russia. Has a very strong performance in many mature and emerging markets, offset still normalizing United States and a weak China.

We've experienced sequential volume recovery throughout the second half of our fiscal year in most markets. Pricing, operational efficiencies, and cost discipline have led to organic gross

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot